{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:07:12Z","timestamp":1790226432216,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.dnarep.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T23:04:55Z","timestamp":1446678295000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells"],"prefix":"10.1016","volume":"37","author":[{"given":"Raafat A.","family":"El-Awady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Semreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Saber-Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Cyprian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taleb H.","family":"Al-Tel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dnarep.2015.10.004_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrc749","article-title":"DNA and its associated processes as targets for cancer therapy","volume":"2","author":"Hurley","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0010","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to playwith knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1101\/gad.2021311","article-title":"Dynamics of DNA damage responseproteins at DNA breaks: a focus on protein modifications","volume":"25","author":"Polo","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","article-title":"Targeting DNA damage response in cancer therapy","volume":"105","author":"Hosoya","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0030","series-title":"Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents","first-page":"371","article-title":"Cyclin-dependent kinase inhibitors and combination therapy: experimental and clinical status","author":"Kelland","year":"2007"},{"issue":"1","key":"10.1016\/j.dnarep.2015.10.004_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2014.07.002","article-title":"Antiproliferative activity of novel imidazopyridine derivatives on castration- resistant human prostate cancer cells","volume":"353","author":"Muniyan","year":"2014","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.dnarep.2015.10.004_bib0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3892\/or.2013.2499","article-title":"A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells","volume":"30","author":"Lee","year":"2013","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.dnarep.2015.10.004_bib0045","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2174\/0929867311320110007","article-title":"Tandem multicomponent reactions toward the design and synthesis of novel antibacterial and cytotoxic motifs","volume":"20","author":"Semreen","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.dnarep.2015.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/15384047.2015.1046023","article-title":"Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy","volume":"16","author":"El-Awady","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"24","key":"10.1016\/j.dnarep.2015.10.004_bib0055","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/jm201181f","article-title":"Design, synthesis, and qualitative structure-activity evaluations of novel \u03b2-secretase inhibitors as potential Alzheimer\u2019s drug leads","volume":"54","author":"Al-Tel","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.taap.2011.06.019","article-title":"Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells","volume":"255","author":"El-Awady","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4161\/cbt.21078","article-title":"Antagonism between curcumin and the topoisomerase II inhibitor etoposide: A study of DNA damage, cell cycle regulation and death pathways","volume":"13","author":"Saleh","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CAD.0b013e328334b0ae","article-title":"Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?","volume":"21","author":"El-Awady","year":"2010","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.dnarep.2015.10.004_bib0080","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1535-7163.MCT-05-0205","article-title":"The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor","volume":"5","author":"Byth","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.dnarep.2015.10.004_bib0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0006-2952(93)90293-6","article-title":"Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells","volume":"45","author":"Ramachandran","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0090","first-page":"99","article-title":"DNA damage response: the players, the network and the role in tumor suppression","volume":"4","author":"Rai","year":"2007","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0095","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.272.29.17907","article-title":"A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis","volume":"272","author":"Thornberry","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.dnarep.2015.10.004_bib0100","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.4161\/15384101.2014.946852","article-title":"Bimodel regulation of p21(waf1) protein as function of DNA damage levels","volume":"13","author":"Buscemi","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1083\/jcb.148.1.59","article-title":"Caspase-dependent cdk activity is a requisite effector of apoptotic death events","volume":"148","author":"Harvey","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.onc.1204203","article-title":"Caspase-mediated CDK2 activation is a critical step to execute transforming growth factor beta1-induced apoptosis in human gastric cancer cells","volume":"20","author":"Kim","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0115","doi-asserted-by":"crossref","first-page":"19207","DOI":"10.1074\/jbc.273.30.19207","article-title":"Cleavage of CDK inhibitor p21(Cip1\/Waf1) by caspases is an early event during DNA damage-induced apoptosis","volume":"273","author":"Gervais","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1097-2765(00)80055-6","article-title":"Cleavage of p21(Cip1\/Waf1) and p27(Kip1) mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspasecascade","volume":"1","author":"Levkau","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0125","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1038\/sj.onc.1202860","article-title":"Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27(Kip1) mediates its anti-apoptotic activity","volume":"18","author":"Eymin","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cdd.2008.142","article-title":"Caspase-dependent cleavage of CDC25A generates an active fragment activating cyclin-dependent kinase 2 during apoptosis","volume":"16","author":"Mazars","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0135","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2009.08.021","article-title":"Caspases and kinases in a death grip","volume":"138","author":"Kurokawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.dnarep.2015.10.004_bib0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0014-5793(02)02440-7","article-title":"Caspase-3 is not essential for DNA fragmentation in MCF7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine PBOX-6","volume":"515","author":"Mc Gee","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.dnarep.2015.10.004_bib0145","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/sj.onc.1204815","article-title":"Apoptosis in the absence of caspase 3","volume":"20","author":"Liang","year":"2001","journal-title":"Oncogene"},{"issue":"35","key":"10.1016\/j.dnarep.2015.10.004_bib0150","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.1073\/pnas.0707715105","article-title":"Executioner caspase-3 and caspase-7 are functionally distinct proteases","volume":"105","author":"Walsh","year":"2008","journal-title":"PNAS"}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786415300380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786415300380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T04:12:07Z","timestamp":1567311127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786415300380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"alternative-id":["S1568786415300380"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2015.10.004","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}